80 related articles for article (PubMed ID: 20874784)
21. Familial epidermolysis bullosa acquisita.
Noe MH; Chen M; Woodley DT; Fairley JA
Dermatol Online J; 2008 Dec; 14(12):2. PubMed ID: 19265615
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of blister induction by autoantibodies.
Sitaru C; Zillikens D
Exp Dermatol; 2005 Dec; 14(12):861-75. PubMed ID: 16274453
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune subepidermal blistering diseases in Uganda: correlation of autoantibody class with age of patients.
Mulyowa GK; Jaeger G; Kabakyenga J; Bröcker EB; Zillikens D; Schmidt E
Int J Dermatol; 2006 Sep; 45(9):1047-52. PubMed ID: 16961507
[TBL] [Abstract][Full Text] [Related]
24. Circulating IgA and IgE autoantibodies in antilaminin-332 mucous membrane pemphigoid.
Natsuga K; Nishie W; Shinkuma S; Moriuchi R; Shibata M; Nishimura M; Hashimoto T; Shimizu H
Br J Dermatol; 2010 Mar; 162(3):513-7. PubMed ID: 19751242
[TBL] [Abstract][Full Text] [Related]
25. Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita.
Kasperkiewicz M; Hirose M; Recke A; Schmidt E; Zillikens D; Ludwig RJ
Br J Dermatol; 2010 May; 162(5):1064-70. PubMed ID: 20222918
[TBL] [Abstract][Full Text] [Related]
26. Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice.
Lazarova Z; Yee C; Darling T; Briggaman RA; Yancey KB
J Clin Invest; 1996 Oct; 98(7):1509-18. PubMed ID: 8833897
[TBL] [Abstract][Full Text] [Related]
27. Molecular basis of blistering skin diseases.
McGrath JA; Eady RA
Hosp Med; 1998 Jan; 59(1):28-32. PubMed ID: 9798561
[TBL] [Abstract][Full Text] [Related]
28. Subepidermal blistering disease presenting with anti-plakin antibodies.
Inaoki M; Nishijima C; Ohyama B; Hashimoto T
Eur J Dermatol; 2012; 22(2):284-5. PubMed ID: 22381589
[No Abstract] [Full Text] [Related]
29. Structural and biophysical characterization of the type VII collagen vWFA2 subdomain leads to identification of two binding sites.
Gebauer JM; Flachsenberg F; Windler C; Richer B; Baumann U; Seeger K
FEBS Open Bio; 2020 Apr; 10(4):580-592. PubMed ID: 32031736
[TBL] [Abstract][Full Text] [Related]
30. Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid.
Maeda JY; Moura AK; Maruta CW; Santi CG; Prisayanh PS; Aoki V
Clin Exp Dermatol; 2006 Sep; 31(5):653-5. PubMed ID: 16901304
[TBL] [Abstract][Full Text] [Related]
31. Pathogenicity of IgG subclass autoantibodies to type VII collagen: induction of dermal-epidermal separation.
Recke A; Sitaru C; Vidarsson G; Evensen M; Chiriac MT; Ludwig RJ; Zillikens D
J Autoimmun; 2010 Jun; 34(4):435-44. PubMed ID: 19948391
[TBL] [Abstract][Full Text] [Related]
32. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB
Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548
[TBL] [Abstract][Full Text] [Related]
33. Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid.
Groth S; Recke A; Vafia K; Ludwig RJ; Hashimoto T; Zillikens D; Schmidt E
Br J Dermatol; 2011 Jan; 164(1):76-82. PubMed ID: 20854435
[TBL] [Abstract][Full Text] [Related]
34. A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading.
Fairley JA; Woodley DT; Chen M; Giudice GJ; Lin MS
J Am Acad Dermatol; 2004 Jul; 51(1):118-22. PubMed ID: 15243536
[TBL] [Abstract][Full Text] [Related]
35. A novel variant of acquired epidermolysis bullosa with autoantibodies against the central triple-helical domain of type VII collagen.
Tanaka H; Ishida-Yamamoto A; Hashimoto T; Hiramoto K; Harada T; Kawachi Y; Shimizu H; Tanaka T; Kishiyama K; Höpfner B; Takahashi H; Iizuka H; Bruckner-Tuderman L
Lab Invest; 1997 Dec; 77(6):623-32. PubMed ID: 9426400
[TBL] [Abstract][Full Text] [Related]
36. Cicatricial pemphigoid with autoantibodies against the laminin 5 gamma 2 subunit.
Dainichi T; Takeshita H; Moroi Y; Urabe K; Yoshida M; Hisamatsu Y; Komai A; Duan H; Koga T; Hashimoto T; Furue M
Eur J Dermatol; 2005; 15(3):189-93. PubMed ID: 15908306
[TBL] [Abstract][Full Text] [Related]
37. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
[TBL] [Abstract][Full Text] [Related]
38. NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage.
Chiriac MT; Roesler J; Sindrilaru A; Scharffetter-Kochanek K; Zillikens D; Sitaru C
J Pathol; 2007 May; 212(1):56-65. PubMed ID: 17380558
[TBL] [Abstract][Full Text] [Related]
39. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
[TBL] [Abstract][Full Text] [Related]
40. Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model.
Li Q; Ujiie H; Shibaki A; Wang G; Moriuchi R; Qiao HJ; Morioka H; Shinkuma S; Natsuga K; Long HA; Nishie W; Shimizu H
J Immunol; 2010 Dec; 185(12):7746-55. PubMed ID: 21076071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
